checking inhaler technique, and improving patient education. The pre-course survey indicated active nurse practitioner involvement in asthma care with a concentration on general clinical ...

A multidisciplinary program for managing asthma in a pediatric population is discussed. A coordinated, multidisciplinary program for managing asthma in children was initiated in November 1997 at a ...

The Primatene Mist inhaler is the only over-the-counter (OTC) asthma inhaler approved by the FDA for the relief of asthma symptoms including wheezing, chest tightness, and shortness of breath in ...

More children stopped using steroid inhalers to control their asthma after a manufacturer discontinued a popular inhaler, a new study says. In 2024, GlaxoSmithKline withdrew Flovent from the market.

If asthma symptoms, such as chest tightness, wheezing, coughing or difficulty breathing, worsen or are not relieved by the blue inhaler, patients are advised to seek urgent medical help.

Because participants had mild to moderate asthma, and long acting beta agonist inhalers-recommended in the latest treatment guidelines-weren't included, the results might not be applicable more ...

Because participants had mild to moderate asthma, and long-acting beta-agonist inhalers—recommended in the latest treatment guidelines—weren't included, the results might not be applicable ...

In 2025, the focus shifts to long-term control measures — prevention, trigger avoidance, proper inhaler ... asthma, but preventing it from controlling our lives. With the right education ...